Andrea "Andi" White, PhD is a healthcare and life sciences executive with three decades of experience operating at the intersection of clinical care, biomedical research, and commercial strategy. Her work has long centered on a core question: how do we accelerate drug discovery and personalized medicine by giving researchers access to the biospecimens and clinical data that make breakthroughs possible — and how do we help people understand that they themselves play a role in that discovery?
Across roles at Microsoft, GE Healthcare, One Medical, and Vizient, she has led initiatives that modernized clinical operations, unlocked research‑grade data, and reshaped how health systems collaborate with industry. Her focus has consistently been on the translational pipeline: how biosamples, clinical histories, and real‑world evidence move from patients to researchers and back into therapies that are more precise, more effective, and more equitable.
As Co‑Founder and CEO of ePluribus Health, she is building the first EHR‑embedded biospecimen and deep‑data marketplace designed to close the long‑standing gap between healthcare and biopharma. Her leadership reflects a deep understanding of the scientific, operational, and commercial barriers that slow therapeutic development — and a commitment to creating infrastructure that allows clinicians, researchers, and industry partners to collaborate seamlessly.
She believes that biosample‑driven breakthroughs are not abstract scientific achievements; they are the result of millions of individual contributions. Her mission is to make that connection visible — to show that every patient, every sample, and every data point can help unlock new therapies, and that bridging healthcare and pharma is essential to bringing personalized medicine to everyone.